The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.
FTC Suing To Stop Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics
The FTC is attempting to stop the sale out of fears it will give the company too much power over rare disease treatments.